The impact of increasing polypharmacy on prescribed drug expenditure—A register-based study in Sweden 2005–2009

Bo Hovstadius and Göran Petersson

Health Policy, 2013, vol. 109, issue 2, 166-174

Abstract: To analyse the impact of the observed increase in the prevalence in polypharmacy on the development of prescribed drug expenditure (PDE) in a national population during five years.

Keywords: Drug cost; Prescribed drugs; Polypharmacy; Register (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851012002576
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:109:y:2013:i:2:p:166-174

DOI: 10.1016/j.healthpol.2012.09.005

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().